Crude oil prices hit 11-month high

WTI crude oil prices surged more than 3% to US$ 53.9, hitting their highest level seen since February 2020. A large draw in the API crude inventories and a weakening US Dollar gave oil prices a fresh boost alongside reflation hopes. The oil report pointed to a 5.82-million-barrel decline in inventories for the week ending January 8th, compared to a baseline forecast of a 1.66-million-barrel drop.

Recently, prices appear to be riding favourable tailwinds since Saudi Arabia unilaterally announced a production cut of 1 million bpd in February and March amid dissents among OPEC+ members. Since then, WTI prices have surged by more than 13% on hope that Saudi’s willingness and ability to cut could effectively rein market supply and shelter prices through the Covid pandemic.

IamFire plc (AQSE:FIRE) is an Investment Issuer Listed on the AQSE Growth Market Exchange. The company has an investment strategy focused on the identification of opportunities in Life Sciences, Technology & Natural Resources.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

More articles like this

Oil prices up as markets await higher stimulus in US

Oil prices were up on Wednesday as markets await the announcement of a higher US relief package during the US President-elect’s inauguration speech later Wednesday, although rising coronavirus cases are capping upward price movements. International benchmark Brent crude

Why there’s still room for oil to go higher

Crude oil prices are on the rise again after a short reversal of fortunes prompted by a huge crude oil inventory build reported by the U.S. EIA last week and renewed worry about demand. And the reason they

Oil up on medical, fiscal and geopolitical combo

Christmas came early for oil prices as a combo of global medical, fiscal and geopolitical developments this week is helping Brent recover the 50+ dollar level it achieved last week. The emergency FDA approval of the Pfizer-BioNTech vaccine